Management of allergy to penicillins and other beta-lactams

Clinical and Experimental Allergy

Volumn 45, Issue 2, 2015, Pages 300-327

  Mirakian, R ^a   Leech, S C ^b   Krishna, M T ^c   Richter, A G ^c   Huber, P A J ^d   Farooque, S ^e   Khan, N ^f   Pirmohamed, M ^g   Clark, A T ^a   Nasser, S M ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d British Society for Allergy and Clinical Immunology   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f GLENFIELD HOSPITAL   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

BSACI; Allergy; Anaphylaxis; Beta lactam; Carbapenem; Cephalosporin; Children; Cross reactivity; Desensitization; Drug provocation test; Epidemiology; Hypersensitivity; Monobactam; Oral challenges; Paediatrics; Penicillin; Serum specific IgE; Skin tests; Standards of Care Committee

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; EPITOPE; IMMUNOGLOBULIN E; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; REAGENT; ANTIINFECTIVE AGENT; BETA LACTAM;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; BASOPHIL ACTIVATION TEST; BETA LACTAM ALLERGY; CHEMICAL STRUCTURE; DESENSITIZATION; DRUG CROSS REACTIVITY; DRUG FATALITY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; DRUG SENSITIZATION; DRUG STRUCTURE; ENZYME LINKED IMMUNOSPOT ASSAY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; GENETIC PREDISPOSITION; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOASSAY; LYMPHOCYTE TRANSFORMATION TEST; PATCH TEST; PENICILLIN ALLERGY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RISK FACTOR; SKIN TEST; T LYMPHOCYTE; URTICARIA; AGE; DISEASE MANAGEMENT;

AGE FACTORS; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DISEASE MANAGEMENT; DRUG HYPERSENSITIVITY; HUMANS; PENICILLINS;

EID: 84923094324     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12468     Document Type: Article

References (233)

1. Powell RJ, Du Toit GL, Siddique N et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007; 37:631-50.
2. Lyons C. Problems of infection and chemotherapy. Ann Surg 1943; 117:894-902.
3. Suchecki AI. Allergic reactions to penicillin. Br Med J 1946; 2:938-40.
4. Gell PGH, Coombs RRA. Clinical aspects of immunology. 2nd edn. Oxford: Blackwell Scientific Publications, 1968.
5. Johansson SG, Hourihane JO, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-24.
6. Lerch M, Pichler WJ. The immunological and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol 2004; 4:411-9.
7. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-93.
8. Torres MJ, Blanca M, Fernandez J et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-72.
9. Richter AG, Nasser SM, Krishna MT. A UK national survey of investigations for beta-lactam hypersensitivity - heterogeneity in practice and a need for national guidelines - on behalf of British Society for Allergy and Clinical Immunology (BSACI). Clin Exp Allergy 2013; 43:941-9.
10. Gomez MB, Torres MJ, Mayorga C et al. Immediate allergic reactions to betalactams: facts and controversies. Curr Opin Allergy Clin Immunol 2004; 4:261-6.
11. Torres MJ, Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am 2010; 94:805-20, xii.
12. Pichichero ME, Zagursky R. Penicillin and Cephalosporin allergy. Ann Allergy Asthma Immunol 2014; 112:404-12.
13. Solensky R. Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 2003; 24:201-20.
14. Nicklas RA, Bernstein IL, Li JT. The diagnosis and management of anaphylaxis: A practice parameter. J Allergy Clin Immunol 1998; 101:S465-528.
15. Kerr JR. Penicillin allergy: a study of incidence as reported by patients. Br J Clin Pract 1994; 48:5-7.
16. Joint Task Force on Practice Parameters, American Academy of Allergy AaI, American College of Allergy AaI, Joint Council of Allergy AaI. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259-73.
17. Apter AJ, Kinman JL, Bilker WB et al. Represcription of penicillin after allergic-like events. J Allergy Clin Immunol 2004; 113:764-70.
18. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15, 438 consecutive inpatients, 1975 to 1982. JAMA 1975; 1986:3358-63.
19. Macy E, Poon K-YT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 2009; 122:778-7.
20. Green GR, Rosenblum AH, Sweet LC. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy. J Allergy Clin Immunol 1977; 60:339-45.
21. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991; 337:1308-10.
22. PART 1: executive summary of disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol 1999; 83:665-70.
23. Antunes J, Silva R, Pacheco D, Travassos R, Filipe P. Occupational contact allergy to cephalosporins. Dermatol Online J 2011; 17:13.
24. Shapiro S, Siskind V, Slone D, Lewis GP, Jick H. Drug rash with ampicillin and other penicillins. Lancet 1969; 2:969-72.
25. Kerns D, Shira JE, Go S, Summers RJ, Schwab JA, Plunket DC. Ampicillin rash in children. Relationship to penicillin allergy and infectious mononucleosis. Am J Dis Child 1973; 125:187-90.
26. Patel BM. Skin rash with infectious mononucleosis and ampicillin. Pediatrics 1967; 40:910-1.
27. Schiavino D, Nucera E, De PT et al. Delayed allergy to aminopenicillins: clinical and immunological findings. Int J Immunopathol Pharmacol 2006; 19:831-40.
28. Lin RY. A perspective on penicillin allergy. Arch Intern Med 1992; 152:930-7.
29. Li JT, Markus PJ, Osmon DR, Estes L, Gosselin VA, Hanssen AD. Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy. Mayo Clin Proc 2000; 75:902-6.
30. Park M, Markus P, Matesic D, Li JT. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 2006; 97:681-7.
31. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: A cohort study. J Allergy Clin Immunol 2014; 133:790-6.
32. Park MA, Li JT. Diagnosis and management of penicillin allergy. Mayo Clin Proc 2005; 80:405-10.
33. Sade K, Holtzer I, Levo Y, Kivity S. The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 2003; 33:501-6.
34. Satta G, Hill V, Lanzman M, Balakrishnan I. beta-lactam allergy: clinical implications and costs. Clin Mol Allergy 2013; 11:2.
35. Macy E, Ngor EW. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract 2013; 1:258-63.
36. Rimawi RH, Cook PP, Gooch M et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 2013; 8:341-5.
37. Macy E, Schatz M, Lin C, Poon KY. The falling rate of positive penicillin skin tests from 1995 to 2007. Perm J 2009; 13:12-8.
38. Park MA, Matesic D, Markus PJ, Li JT. Female sex as a risk factor for penicillin allergy. Ann Allergy Asthma Immunol 2007; 99:54-8.
39. Park M. Intradermal penicillin skin test is more likely to be positive compared to prick skin test in patients with a history of penicillin allergy. Clin Transl Allergy 2014; 4(Suppl. 3):101.
40. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 2001; 161:15-21.
41. Idsoe O, Guthe T, Willcox RR, De Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ Geneva, Switzerland 1968; 38:159-88.
42. Napoli DC, Neeno TA. Anaphylaxis to Benzathine Penicillin G. Pediatr Asthma Allergy Immunol 2000; 14:329-32.
43. Sue MA, Noritake DT, Klaustermeyer WB. Penicillin anaphylaxis: fatality in elderly patients without a history of penicillin allergy. Am J Emerg Med 1988; 6:456-8.
44. Blanca M, Romano A, Torres MJ et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64:183-93.
45. Kaufman DW. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study; International Collaborative Study of Severe Anaphylaxis. Pharmacoepidemiol Drug Saf 2003; 12:195-202.
46. Delage C, Irey NS. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forensic Sci 1972; 17:525-40.
47. Lenler-Petersen P, Hansen D, Andersen M, Sorensen HT, Bille H. Drug-related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995; 48:1185-8.
48. Pumphrey RS, Davis S. Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 1999; 353:1157-8.
49. Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother 2007; 60:1172-3.
50. Holm A, Mosbech H. Challenge test results in patients with suspected penicillin allergy, but no specific IgE. Allergy Asthma Immunol Res 2011; 3:118-22.
51. Wong BB, Keith PK, Waserman S. Clinical history as a predictor of penicillin skin test outcome. Ann Allergy Asthma Immunol 2006; 97:169-74.
52. Fox S, Park MA. Penicillin skin testing in the evaluation and management of penicillin allergy. Ann Allergy Asthma Immunol 2011; 106:1-7.
53. Adkinson NF Jr. Risk factors for drug allergy. J Allergy Clin Immunol 1984; 74:567-72.
54. Thong BY, Vervloet D. Disease summaries-Drug allergies. Available from:http://www.worldallergy.org/professional/allergic_diseases_center/drugallergy/, WAO (World Allergy Organization), Last accessed 22 December 2014.
55. Park BK, Pirmohamed M, Kitteringham NR. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992; 34:377-95.
56. Ramesh S. Antibiotic hypersensitivity in patients with CF. Clin Rev Allergy Immunol 2002; 23:123-41.
57. Wills R, Henry RL, Francis JL. Antibiotic hypersensitivity reactions in cystic fibrosis. J Paediatr Child Health 1998; 34:325-9.
58. Moss RB, McClelland E, Williams RR, Hilman BC, Rubio T, Adkinson NF. Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics. Rev Infect Dis 1991; 13(Suppl. 7):S598-607.
59. Moss RB. Drug allergy in cystic fibrosis. Clin Rev Allergy 1991; 9:211-29.
60. Pleasants RA, Walker TR, Samuelson WM. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest 1994; 106:1124-8.
61. Burrows JA, Nissen LM, Kirkpatrick CM, Bell SC. Beta-lactam allergy in adults with cystic fibrosis. J Cyst Fibros 2007; 6:297-303.
62. Arroliga ME, Pien L. Penicillin allergy: consider trying penicillin again. Cleve Clin J Med 2003; 70:313-8, 320.
63. Adkinson NF Jr. Beta-lactam crossreactivity. Clin Exp Allergy 1998; 28(Suppl. 4):37-40.
64. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy 2007; 37:989-99.
65. Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E et al. Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro. Eur J Dermatol 2010; 20:68-73.
66. Battegay M, Opravil M, Wuthrich B, Luthy R. Rash with amoxycillin-clavulanate therapy in HIV-infected patients. Lancet 1989; 2:1100.
67. Daly AK, Donaldson PT, Bhatnagar P et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41:816-9.
68. Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis 2009; 29:400-11.
69. Hautekeete ML, Horsmans Y, Van WC et al. HLA association of amoxicillin-clavulanate-induced hepatitis. Gastroenterology 1999; 117:1181-6.
70. Romano A, De SA, Romito A et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann Allergy Asthma Immunol 1998; 80:433-7.
71. Apter AJ, Schelleman H, Walker A, Addya K, Rebbeck T. Clinical and genetic risk factors of self-reported penicillin allergy. J Allergy Clin Immunol 2008; 122:152-8.
72. Kurtz KM, Beatty TL, Adkinson NF Jr. Evidence for familial aggregation of immunologic drug reactions. J Allergy Clin Immunol 2000; 105:184-5.
73. Huang CZ, Yang J, Qiao HL, Jia LJ. Polymorphisms and haplotype analysis of IL-4Ralpha Q576R and I75V in patients with penicillin allergy. Eur J Clin Pharmacol 2009; 65:895-902.
74. Gueant-Rodriguez RM, Romano A, Beri-Dexheimer M, Viola M, Gaeta F, Gueant JL. Gene-gene interactions of IL13 and IL4RA variants in immediate allergic reactions to betalactam antibiotics. Pharmacogenet Genomics 2006; 16:713-9.
75. Huang CZ, Zou D, Yang J, Qiao HL. Polymorphisms of STAT6 and specific serum IgE levels in patients with penicillin allergy. Int J Clin Pharmacol Ther 2012; 50:461-7.
76. Lucena MI, Molokhia M, Shen Y et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011; 141:338-47.
77. Gruchalla RS. 10. Drug allergy. J Allergy Clin Immunol 2003; 111:S548-59.
78. Levine BB, Ovary Z. Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J Exp Med 1961; 114:875-904.
79. Levine BB. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. N Engl J Med 1966; 275:1115-25.
80. Macy E, Richter PK, Falkoff R, Zeiger R. Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents. J Allergy Clin Immunol 1997; 100:586-91.
81. Bousquet PJ, Co-Minh HB, Arnoux B, Daures JP, Demoly P. Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy. J Allergy Clin Immunol 2005; 115:1314-6.
82. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993; 270:2456-63.
83. Baldo BA, Zhao Z, Pham NH. Antibiotic allergy: immunochemical and clinical considerations. Curr Allergy Asthma Rep 2008; 8:49-55.
84. Zhao Z, Baldo BA, Rimmer J. beta-Lactam allergenic determinants: fine structural recognition of a cross-reacting determinant on benzylpenicillin and cephalothin. Clin Exp Allergy 2002; 32:1644-50.
85. Baldo BA. Penicillins and cephalosporins as allergens-structural aspects of recognition and cross-reactions. Clin Exp Allergy 1999; 29:744-9.
86. Antunez C, Blanca-Lopez N, Torres MJ et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 2006; 117:404-10.
87. Sanchez-Sancho F, Perez-Inestrosa E, Suau R et al. Synthesis, characterization and immunochemical evaluation of cephalosporin antigenic determinants. J Mol Recognit 2003; 16:148-56.
88. Perez-Inestrosa E, Suau R, Montanez MI et al. Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol 2005; 5:323-30.
89. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005; 115:1048-57.
90. Olaison L, Belin L, Hogevik H, Alestig K. Incidence of beta-lactam-induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis. Arch Intern Med 1999; 159:607-15.
91. Clark BM, Kotti GH, Shah AD, Conger NG. Severe serum sickness reaction to oral and intramuscular penicillin. Pharmacotherapy 2006; 26:705-8.
92. Padial A, Antunez C, Blanca-Lopez N et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38:822-8.
93. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57:45-51.
94. Klemola E. Hypersensitivity reactions to ampicillin in cytomegalovirus mononucleosis. Scand J Infect Dis 1970; 2:29-31.
95. Hernanto M, Yudani BA, Pudjiati SR, Indrastuti N. DRESS syndrome from cefadroxil confirmed by positive patch test. Allergy 2007; 62:1216-7.
96. Bierman CW, Pierson WE, Zeitz SJ, Hoffman LS, VanArsdel PP Jr. Reactions associated with ampicillin therapy. JAMA 1972; 220:1098-100.
97. Mirakian R, Ewan PW, Durham SR et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009; 39:43-61.
98. Dworzynski K, Ardern-Jones M, Nasser S. Diagnosis and management of drug allergy in adults, children and young people: summary of NICE guidance. BMJ 2014; 349:g4852.
99. Blanca M, Romano A, Torres MJ, Demoly P, DeWeck A. Continued need of appropriate betalactam-derived skin test reagents for the management of allergy to betalactams. Clin Exp Allergy 2007; 37:166-73.
100. Romano A, Demoly P. Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol 2007; 7:299-303.
101. Kranke B, Aberer W. Skin testing for IgE-mediated drug allergy. Immunol Allergy Clin North Am 2009; 29:503-16.
102. Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 2008; 38:185-90.
103. Bousquet PJ, Gaeta F, Bousquet-Rouanet L, Lefrant JY, Demoly P, Romano A. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des 2008; 14:2792-802.
104. Sullivan TJ, Wedner HJ, Shatz GS, Yecies LD, Parker CW. Skin testing to detect penicillin allergy. J Allergy Clin Immunol 1981; 68:171-80.
105. Blanca M, Torres MJ, Garcia JJ et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 1999; 103:918-24.
106. Romano A, Gaeta F, Valluzzi RL, Zaffiro A, Caruso C, Quaratino D. Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins. Allergy 2014; 69:806-9.
107. Yoon SY, Park SY, Kim S et al. Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge. Allergy 2013; 68:938-44.
108. Weber-Mani U, Pichler WJ. Anaphylactic shock after intradermal testing with betalactam antibiotics. Allergy 2008; 63:785.
109. Co Minh HB, Bousquet PJ, Fontaine C, Kvedariene V, Demoly P. Systemic reactions during skin tests with beta-lactams: a risk factor analysis. J Allergy Clin Immunol 2006; 117:466-8.
110. Valyasevi MA, Van Dellen RG. Frequency of systematic reactions to penicillin skin tests. Ann Allergy Asthma Immunol 2000; 85:363-5.
111. Nolan RC, Puy R, Deckert K, O'Hehir RE, Douglass JA. Experience with a new commercial skin testing kit to identify IgE-mediated penicillin allergy. Intern Med J 2008; 38:357-61.
112. Van Dellen RG. Skin testing for penicillin allergy. J Allergy Clin Immunol 1981; 68:169-70.
113. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79:660-77.
114. Riezzo I, Bello S, Neri M, Turillazzi E, Fineschi V. Ceftriaxone intradermal test-related fatal anaphylactic shock: a medico-legal nightmare. Allergy 2010; 65:130-1.
115. Romano A, Bousquet-Rouanet L, Viola M, Gaeta F, Demoly P, Bousquet PJ. Benzylpenicillin skin testing is still important in diagnosing immediate hypersensitivity reactions to penicillins. Allergy 2009; 64:249-53.
116. Blanca M, Vega JM, Garcia J et al. Allergy to penicillin with good tolerance to other penicillins; study of the incidence in subjects allergic to beta-lactams. Clin Exp Allergy 1990; 20:475-81.
117. Brockow K, Garvey LH, Aberer W et al. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013; 68:702-12.
118. Demoly P, Romano A. Update on beta-lactam allergy diagnosis. Curr Allergy Asthma Rep 2005; 5:9-14.
119. Rodriguez-Bada JL, Montanez MI, Torres MJ et al. Skin testing for immediate hypersensitivity to betalactams: comparison between two commercial kits. Allergy 2006; 61:947-51.
120. Romano A, Viola M, Bousquet PJ et al. A comparison of the performance of two penicillin reagent kits in the diagnosis of beta-lactam hypersensitivity. Allergy 2007; 62:53-8.
121. Matheu V, Perez E, Gonzalez R et al. Assessment of a new brand of determinants for skin testing in a large group of patients with suspected beta-lactam allergy. J Investig Allergol Clin Immunol 2007; 17:257-60.
122. Richter AG, Wong G, Goddard S et al. Retrospective case series analysis of penicillin allergy testing in a UK specialist regional allergy clinic. J Clin Pathol 2011; 64:1014-8.
123. Matheu V, Perez-Rodriguez E, Sanchez-Machin I, de la TF, Garcia-Robaina JC. Major and minor determinants are high-performance skin tests in beta-lactam allergy diagnosis. J Allergy Clin Immunol 2005; 116:1167-8.
124. Torres MJ, Mayorga C, Blanca M. Urticaria and Anaphylaxis due to Betalactams (Penicillins and Cephalosporins). In: Pichler WJ, ed. Drug hypersensitivity. Basel: Karger, 2007:190-203.
125. Torres MJ, Romano A, Mayorga C et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001; 56:850-6.
126. Torres MJ, Ariza A, Fernandez J et al. Role of minor determinants of amoxicillin in the diagnosis of immediate allergic reactions to amoxicillin. Allergy 2010; 65:590-6.
127. Romano A, Gueant-Rodriguez RM, Viola M, Pettinato R, Gueant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004; 141:16-22.
128. Sanchez-Morillas L, Perez-Ezquerra PR, Reano-Martos M, Laguna-Martinez JJ, Sanz ML, Martinez LM. Selective allergic reactions to clavulanic acid: a report of 9 cases. J Allergy Clin Immunol 2010; 126:177-9.
129. Torres MJ, Ariza A, Mayorga C et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 2010; 125:502-5.
130. Gonzalez de OD, Losada PA, Caballer BL, Vazquez Gonzalez AC, Diéguez Pastor MC, Cuevas AM. Selective sensitization to clavulanic acid and penicillin V. J Investig Allergol Clin Immunol 2007; 17:119-21.
131. Romano A, Gueant-Rodriguez RM, Viola M et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005; 35:1234-42.
132. Testi S, Severino M, Iorno ML et al. Nonirritating concentration for skin testing with cephalosporins. J Investig Allergol Clin Immunol 2010; 20:171-2.
133. Empedrad R, Darter AL, Earl HS, Gruchalla RS. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003; 112:629-30.
134. Romano A, Blanca M, Torres MJ et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004; 59:1153-60.
135. Brockow K, Romano A. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des 2008; 14:2778-91.
136. Torres MJ, Sanchez-Sabate E, Alvarez J et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004; 59:219-24.
137. Romano A, Viola M, Mondino C et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002; 129:169-74.
138. Patriarca G, D'Ambrosio C, Schiavino D, Larocca LM, Nucera E, Milani A. Clinical usefulness of patch and challenge tests in the diagnosis of cell-mediated allergy to betalactams. Ann Allergy Asthma Immunol 1999; 83:257-66.
139. Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ. The very limited usefulness of skin testing with penicilloyl-polylysine and the minor determinant mixture in evaluating nonimmediate reactions to penicillins. Allergy 2010; 65:1104-7.
140. Bourke J, Coulson I, English J. Guidelines for care of contact dermatitis. Br J Dermatol 2001; 145:877-85.
141. Bourke J, Coulson I, English J. Guidelines for the management of contact dermatitis: an update. Br J Dermatol 2009; 160:946-54.
142. Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45:265-8.
143. Brajon D, Menetre S, Waton J, Poreaux C, Barbaud A. Non-irritant concentrations and amounts of active ingredient in drug patch tests. Contact Dermatitis 2014; 71:170-5.
144. Wilkinson DS, Fregert S, Magnusson B et al. Terminology of contact dermatitis. Acta Derm Venereol 1970; 50:287-92.
145. Gonzalo-Garijo MA, Rodriguez-Nevado I, De AD. Patch tests for diagnosis of delayed hypersensitivity to cephalosporins. Allergol Immunopathol (Madr) 2006; 34:39-41.
146. Romano A, Viola M, Gaeta F, Rumi G, Maggioletti M. Patch testing in non-immediate drug eruptions. Allergy Asthma Clin Immunol 2008; 4:66-74.
147. Barbaud A, Collet E, Milpied B et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013; 168:555-62.
148. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152:968-74.
149. Wolkenstein P, Chosidow O, Flechet ML et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35:234-6.
150. Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 2013; 68:1057-64.
151. Weiss ME, Adkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy 1988; 18:515-40.
152. Sogn DD, Evans R III, Shepherd GM et al. Results of the national institute of allergy and infectious diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992; 152:1025-32.
153. Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up. Allergy 2002; 57:1151-8.
154. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140:1001-6.
155. Bousquet PJ, Kvedariene V, Co-Minh HB et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy 2007; 62:872-6.
156. Torres MJ, Mayorga C, Leyva L et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy 2002; 32:270-6.
157. The Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259-73.
158. Torres MJ, Mayorga C, Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol 2009; 19:80-90.
159. Parker PJ, Parrinello JT, Condemi JJ, Rosenfeld SI. Penicillin resensitization among hospitalized patients. J Allergy Clin Immunol 1991; 88:213-7.
160. Solensky R, Earl HS, Gruchalla RS. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002; 162:822-6.
161. Bittner A, Greenberger PA. Incidence of resensitization after tolerating penicillin treatment in penicillin-allergic patients. Allergy Asthma Proc 2004; 25:161-4.
162. Demoly P, Romano A, Botelho C et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 2010; 65:327-32.
163. Demoly P, Adkinson NF, Brockow K et al. International Consensus on drug allergy. Allergy 2014; 69:420-37.
164. Blanca M, Mayorga C, Torres MJ et al. Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy 2001; 56:862-70.
165. Fontaine C, Mayorga C, Bousquet PJ et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 2007; 62:47-52.
166. Ebo DG, Leysen J, Mayorga C, Rozieres A, Knol EF, Terreehorst I. The in vitro diagnosis of drug allergy: status and perspectives. Allergy 2011; 66:1275-86.
167. Vultaggio A, Matucci A, Virgili G et al. Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies. Clin Exp Allergy 2009; 39:838-44.
168. Torres MJ, Mayorga C, Cornejo-Garcia JA, Romano A, Blanca M. IgE antibodies to penicillin in skin test negative patients. Allergy 2002; 57:965.
169. Macy E, Goldberg B, Poon KY. Use of commercial anti-penicillin IgE fluorometric enzyme immunoassays to diagnose penicillin allergy. Ann Allergy Asthma Immunol 2010; 105:136-41.
170. De Weck AL, Sanz ML, Gamboa PM et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008; 146:177-89.
171. Hausmann OV, Gentinetta T, Bridts CH, Ebo DG. The basophil activation test in immediate-type drug allergy. Immunol Allergy Clin North Am 2009; 29:555-66.
172. Sanz ML, Gamboa PM, Antepara I et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002; 32:277-86.
173. Torres MJ, Padial A, Mayorga C et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 2004; 34:1768-75.
174. Fernandez TD, Torres MJ, Blanca-Lopez N et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 2009; 64:242-8.
175. Rozieres A, Hennino A, Rodet K et al. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 2009; 64:534-42.
176. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59:809-20.
177. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987; 107:204-15.
178. Patriarca G, Schiavino D, Lombardo C et al. Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams. Int J Immunopathol Pharmacol 2008; 21:375-9.
179. Buonomo A, Nucera E, De PT et al. Tolerability of aztreonam in patients with cell-mediated allergy to beta-lactams. Int Arch Allergy Immunol 2011; 155:155-9.
180. Vega JM, Blanca M, Garcia JJ et al. Tolerance to aztreonam in patients allergic to beta-lactam antibiotics. Allergy 1991; 46:196-202.
181. Soto Alvarez J, Sacristan del Castillo JA, Sampedro Garcia I, Ortiz MJ. Immediate hypersensitivity to aztreonam. Lancet 1990; 335:1094.
182. Perez PA, Gomez MM, Minguez MA, Trampal GA, de Paz AS, Rodriguez MM. Aztreonam and ceftazidime: evidence of in vivo cross allergenicity. Allergy 1998; 53:624-5.
183. Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems. J Allergy Clin Immunol 2010; 126:994-9.
184. Saxon A, Adelman DC, Patel A, Hajdu R, Calandra GB. Imipenem cross-reactivity with penicillin in humans. J Allergy Clin Immunol 1988; 82:213-7.
185. Prescott WA Jr, Kusmierski KA. Clinical importance of carbapenem hypersensitivity in patients with self-reported and documented penicillin allergy. Pharmacotherapy 2007; 27:137-42.
186. Prescott WA Jr, DePestel DD, Ellis JJ, Regal RE. Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis 2004; 38:1102-7.
187. Sodhi M, Axtell SS, Callahan J, Shekar R. Is it safe to use carbapenems in patients with a history of allergy to penicillin? J Antimicrob Chemother 2004; 54:1155-7.
188. Romano A, Viola M, Gueant-Rodriguez RM, Gaeta F, Pettinato R, Gueant JL. Imipenem in patients with immediate hypersensitivity to penicillins. N Engl J Med 2006; 354:2835-7.
189. Romano A, Viola M, Gueant-Rodriguez RM, Gaeta F, Valluzzi R, Gueant JL. Brief communication: tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med 2007; 146:266-9.
190. Cunha BA, Hamid NS, Krol V, Eisenstein L. Safety of meropenem in patients reporting penicillin allergy: lack of allergic cross reactions. J Chemother 2008; 20:233-7.
191. Schiavino D, Nucera E, Lombardo C et al. Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to beta-lactams. Allergy 2009; 64:1644-8.
192. Romano A, Gaeta F, Valluzzi RL et al. Absence of cross-reactivity to carbapenems in patients with delayed hypersensitivity to penicillins. Allergy 2013; 68:1618-21.
193. Dash CH. Penicillin allergy and the cephalosporins. J Antimicrob Chemother 1975; 1:107-18.
194. Petz LD. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis 1978; 137(Suppl.):S74-9.
195. Goodman EJ, Morgan MJ, Johnson PA, Nichols BA, Denk N, Gold BB. Cephalosporins can be given to penicillin-allergic patients who do not exhibit an anaphylactic response. J Clin Anesth 2001; 13:561-4.
196. Daulat S, Solensky R, Earl HS, Casey W, Gruchalla RS. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy Clin Immunol 2004; 113:1220-2.
197. Fonacier L, Hirschberg R, Gerson S. Adverse drug reactions to a cephalosporins in hospitalized patients with a history of penicillin allergy. Allergy Asthma Proc 2005; 26:135-41.
198. Madaan A, Li JT. Cephalosporin allergy. Immunol Allergy Clin North Am 2004; 24:463-vii.
199. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg 2007; 136:340-7.
200. Novalbos A, Sastre J, Cuesta J et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy 2001; 31:438-43.
201. Sastre J, Quijano LD, Novalbos A et al. Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin. Allergy 1996; 51:383-6.
202. Miranda A, Blanca M, Vega JM et al. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 1996; 98:671-7.
203. Trcka J, Seitz CS, Brocker EB, Gross GE, Trautmann A. Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin. J Antimicrob Chemother 2007; 60:107-11.
204. Romano A, Gaeta F, Valluzzi RL et al. Diagnosing nonimmediate reactions to cephalosporins. J Allergy Clin Immunol 2012; 129:1166-9.
205. Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 2011; 127:S67-73.
206. Macy E, Ngor E. Recommendations for the management of beta-lactam intolerance. Clin Rev Allergy Immunol. 2014 Aug; 47(1):46-55.
207. Cernadas JR, Brockow K, Romano A et al. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010; 65:1357-66.
208. Liu A, Fanning L, Chong H et al. Desensitization regimens for drug allergy: state of the art in the 21st century. Clin Exp Allergy 2011; 41:1679-89.
209. Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ. Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol 1982; 69:275-82.
210. Naclerio R, Mizrahi EA, Adkinson NF Jr. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 1983; 71:294-301.
211. Borish L, Tamir R, Rosenwasser LJ. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987; 80:314-9.
212. Stark BJ, Wendel GD, Sullivan TJ. Oral desensitization for penicillin sensitivity. JAMA 1987; 257:1474.
213. Wendel GD Jr, Stark BJ, Jamison RB, Molina RD, Sullivan TJ. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985; 312:1229-32.
214. Sullivan TJ. Drug allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, eds. Allergy: principles and practice. St. Louis, MO: Mosby, 1993:1726-46.
215. Win PH, Brown H, Zankar A, Ballas ZK, Hussain I. Rapid intravenous cephalosporin desensitization. J Allergy Clin Immunol 2005; 116:225-8.
216. Solensky R. Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin. Clin Allergy Immunol 2004; 18:585-606.
217. Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 2008; 121:572-6.
218. Castells M. Rapid desensitization of hypersensitivity reactions to chemotherapy agents. Curr Drug Saf 2006; 1:243-51.
219. Castells M. Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Curr Opin Allergy Clin Immunol 2006; 6:271-7.
220. Castells MC, Tennant NM, Sloane DE et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008; 122:574-80.
221. Burrows JA, Toon M, Bell SC. Antibiotic desensitization in adults with cystic fibrosis. Respirology 2003; 8:359-64.
222. Parmar JS, Nasser S. Antibiotic allergy in cystic fibrosis. Thorax 2005; 60:517-20.
223. Scherer K, Brockow K, Aberer W et al. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group. Allergy 2013; 68:844-52.
224. Ponvert C, Weilenmann C, Wassenberg J et al. Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy 2007; 62:42-6.
225. Caubet JC, Kaiser L, Lemaitre B, Fellay B, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol 2011; 127:218-22.
226. Rebelo GE, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy 2008; 38:191-8.
227. Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children. Pediatr Allergy Immunol 2008; 19:634-8.
228. Orhan F, Karakas T, Cakir M et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatr Allergy Immunol 2008; 19:82-5.
229. Romano A, Gaeta F, Valluzzi RL, Alonzi C, Viola M, Bousquet PJ. Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics 2008; 122:521-7.
230. Ponvert C, Perrin Y, Bados-Albiero A et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011; 22:411-8.
231. Rallis E, Balatsouras DG, Kouskoukis C, Verros C, Homsioglou E. Drug eruptions in children with ENT infections. Int J Pediatr Otorhinolaryngol 2006; 70:53-7.
232. Blanca-Lopez N, Zapatero L, Alonso E et al. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 2009; 64:229-33.
233. Hershkovich J, Broides A, Kirjner L, Smith H, Gorodischer R. Beta lactam allergy and resensitization in children with suspected beta lactam allergy. Clin Exp Allergy 2009; 39:726-30.